<DOC>
	<DOCNO>NCT01264523</DOCNO>
	<brief_summary>The main objective study evaluate effect anthropometric , glucose metabolism lipid profile biomarkers exchange high-protein , low-glycemic index product ( 40-30-30 ) habitual breakfast , mid-morning afternoon snack type-2 diabetes patient follow chronologically schedule pattern .</brief_summary>
	<brief_title>Nutritional Intervention With Moderately High-protein , Low-glycemic Load Products Type-2 Diabetes Patients</brief_title>
	<detailed_description>Type 2 diabetes prevalence adult grow last year many society , accompany high incidence obesity-related cardiovascular risk factor . Indeed , obesity relevant overnutrition disease worldwide , dramatic self-esteem problem aesthetic issue , since associate different metabolic disorder coronary disease , hypertension , certain tumor , dislipidemia , biliary disorder , immunodeficiency insulin resistance . Different study show efficacy low-fat diet weight reduction , associate improvement overweight-related chronic pathological condition . Additionally , moderate increase protein content ( 30 % total caloric intake ) diet inclusion low-glycemic index product show good tool weight loss maintenance . Recent study also show benefit partial nutritional intervention , mainly modify breakfast intake , anthropometrical cardiovascular risk factor overweight patient . The study design longitudinal nutritional intervention two consecutive 4-week period : week 0 4 , volunteer follow habitual diet . The second period ( week 4 8 ) , volunteer ' habitual breakfast , mid-morning afternoon snack substitute 40-30-30 product , without change parameter habitual diet lifestyle .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<criteria>Clinically diagnose type2 Diabetes Under dietary treatment Metformin Body Mass Index ( BMI ) Between 22 35 kg/m2 BMI 22 35 kg/m2 To follow pharmacological treatment drug metformin To already insulindependent To concomitant pharmacological treatment weight loss , hormonal substitutive therapy , alter thyroid function , etc . without stable dosage ( least three month prior begin study ) . To suffer complication due type 2 diabetes ( microangiopathy , polyneuropathy , cardiopathy , hepatic renal impairment , etc ) To recent ( less 3 month begin study ) uncontrolled diagnostic hypercholesterolemia and/or hypertriglyceridemia .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>chrononutrition</keyword>
	<keyword>moderately high protein</keyword>
	<keyword>glycemic index</keyword>
	<keyword>type-2 diabetes</keyword>
	<keyword>overweight</keyword>
	<keyword>obesity</keyword>
	<keyword>weight management</keyword>
</DOC>